Financials
- Market Capitalization 154.26 M
- Employee 152
- Founded 2013
- CEO N/A
- Website www.lenz-tx.com
- Headquarter Delaware, United States
- FIGI BBG00XDH4NZ2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.61
Relación precio/flujo de caja
24.15
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3774 | NRXP NRX Pharmaceuticals, Inc. - Common Stock | 4.35 USD | +4.82% | +4.57% | +11.54% | +144.38% | 157.60 M USD | ||
| 3787 | HUMA Humacyte, Inc. - Common Stock | 0.71 USD | +2.90% | -7.79% | -34.26% | -71.26% | 157.63 M USD | ||
| 3796 | ADCT ADC Therapeutics SA Common Shares | 1.24 USD | -0.80% | -8.15% | +14.81% | -62.99% | 157.72 M USD | ||
| 3798 | YDES YD Bio Limited - Ordinary Shares | 2.11 USD | -1.86% | +5.50% | -35.28% | -73.63% | 149.37 M USD |